|LabCorp Investor & Analyst Day Presentation|
LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of over $10 billion in ...Read More >>
LabCorp and Appalachian Regional Healthcare Create Comprehensive Laboratory Collaboration
LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest
Covance Forms Immunology & Immunotoxicology Unit Focused on Biologic Drug Development
There are currently no events scheduled.
|Print Page | E-mail Page | RSS Feeds | E-mail Alerts | IR Contacts | Tear Sheet|